Both in Pharmaceuticals
Veru vs SCYNEXIS
Over the past year VERU returned −16.9% and SCYX returned −25.4%; their daily moves had a correlation of 0.04.
VERU −16.9% SCYX −25.4%Growth of $1, one year, split-adjusted
| Metric | VERU | SCYX |
|---|---|---|
| Price | $2.16 | $3.81 |
| Market cap | $36.8M | $37.9M |
| Today | −1.37% | +1.06% |
| 1 month | −13.9% | −25.6% |
| 6 months | −4.0% | −51.6% |
| Year to date | +0.9% | −24.7% |
| 1 year | −28.2% | −30.7% |
| Revenue growth (YoY) | — | −82.8% |
| Gross margin | — | 100.0% |
| Net margin | — | 3147.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.0× |
| Net cash | $25.8M | $54.1M |
| Dividend yield | — | — |
| Volatility (60d) | 63.7% | 64.2% |
| Short % of float | 10.1% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).